Home › Maag-darmkanker

Maag-darmkanker klinische studies rekruteren in de VS

71 studies voor Maag-darmkanker rekruteren deelnemers op locaties doorheen de Verenigde Staten.

Steden met de meeste studies

• Houston, TX21 studies
• Boston, MA15 studies
• New York City, NY12 studies
• Nashville, TN10 studies
• Los Angeles, CA9 studies
• Dallas, TX8 studies
• Durham, NC8 studies
• Baltimore, MD8 studies
• Cincinnati, OH8 studies
• Arlington, VA8 studies
• San Antonio, TX7 studies
• Baldwin Park, CA7 studies
• Seattle, WA7 studies
• Philadelphia, PA6 studies
• St. Louis, MO6 studies
• Grand Rapids, MI6 studies
• Aurora, CO6 studies
• Atlanta, GA5 studies
• Washington, DC5 studies
• Chicago, IL5 studies
• Indianapolis, IN5 studies
• San Francisco, CA5 studies
• Tampa, FL5 studies
• Queens, NY5 studies
• San Diego, CA4 studies
• Omaha, NE4 studies
• Mountain View, CA4 studies
• New Haven, CT4 studies
• Pittsburgh, PA4 studies
• Rochester, MN4 studies
• Salt Lake City, UT4 studies
• Ann Arbor, MI4 studies
• Sacramento, CA4 studies
• Oklahoma City, OK4 studies
• Sarasota, FL4 studies
• Phoenix, AZ4 studies
• Detroit, MI4 studies
• Columbus, OH4 studies
• Santa Monica, CA4 studies
• Milwaukee, WI3 studies

Per staat

• Arizona8 studies
• Arkansas3 studies
• Californië28 studies
• Colorado9 studies
• Connecticut5 studies
• Florida15 studies
• Georgia7 studies
• Illinois8 studies
• Indiana6 studies
• Iowa3 studies
• Kansas5 studies
• Louisiana4 studies
• Maine3 studies
• Maryland14 studies
• Massachusetts15 studies
• Michigan13 studies
• Minnesota7 studies
• Missouri6 studies
• Nebraska5 studies
• New Jersey3 studies
• New Mexico3 studies
• New York14 studies
• North Carolina11 studies
• Ohio15 studies
• Oklahoma4 studies
• Oregon3 studies
• Pennsylvania9 studies
• South Carolina3 studies
• South Dakota3 studies
• Tennessee13 studies
• Texas26 studies
• Utah4 studies
• Virginia9 studies
• Washington8 studies
• Wisconsin7 studies

Recent bijgewerkte studies

Officiële studietekst (Engels)

Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.